HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dystrophic epidermolysis bullosa inversa with COL7A1 mutations and absence of GDA-J/F3 protein.

Abstract
Epidermolysis bullosa dystrophica inversa (DEB-I) is a very rare disease characterized by autosomal recessive inheritance that causes blistering and erosions on the trunk and extremities occurring in early infancy with a predilection for flexural and mucosal areas thereafter. Ultrastructural findings show dermolytic blistering and absent or rudimentary anchoring fibrils as in generalized forms of dystrophic epidermolysis bullosa. Immunoreactivity for type VII collagen, however, is preserved. We present two patients with DEB-I with compound heterozygosity for the two different COL7A1 mutations, one of them (Arg2069Cys in exon 74) carried by the heterozygous mother, the other one (Lys142Arg in exon 3) carried by the heterozygous father, accompanied by absence of the associated anchoring fibrils protein GDA-J/F3.
AuthorsPeter Kahofer, Leena Bruckner-Tuderman, Dieter Metze, Henny Lemmink, Hans Scheffer, Josef Smolle
JournalPediatric dermatology (Pediatr Dermatol) 2003 May-Jun Vol. 20 Issue 3 Pg. 243-8 ISSN: 0736-8046 [Print] United States
PMID12787275 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Cell Adhesion Molecules, Neuronal
  • Collagen Type VII
Topics
  • Adolescent
  • Biopsy, Needle
  • Cell Adhesion Molecules, Neuronal (genetics)
  • Child
  • Collagen Type VII (genetics)
  • DNA Mutational Analysis
  • Epidermolysis Bullosa Dystrophica (genetics, pathology)
  • Fluorescent Antibody Technique, Indirect
  • Genes, Recessive
  • Genetic Predisposition to Disease
  • Heterozygote
  • Humans
  • Immunohistochemistry
  • Male
  • Microscopy, Immunoelectron
  • Mutation
  • Netherlands
  • Pedigree
  • Prognosis
  • Risk Assessment

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: